TY  - GEN
AU  - Shi,Yuanyuan
AU  - Gochuico,Bernadette R
AU  - Yu,Guoying
AU  - Tang,Xiaomeng
AU  - Osorio,Juan C
AU  - Fernandez,Isis E
AU  - Risquez,Cristobal F
AU  - Patel,Avignat S
AU  - Shi,Ying
AU  - Wathelet,Marc G
AU  - Goodwin,Andrew J
AU  - Haspel,Jeffrey A
AU  - Ryter,Stefan W
AU  - Billings,Eric M
AU  - Kaminski,Naftali
AU  - Morse,Danielle
AU  - Rosas,Ivan O
TI  - Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling
SN  - 1535-4970
PY  - 2013///1126
KW  - Animals
KW  - Apoptosis
KW  - Bleomycin
KW  - administration & dosage
KW  - Bronchoalveolar Lavage
KW  - Caveolin 1
KW  - drug effects
KW  - Disease Models, Animal
KW  - Gene Expression Profiling
KW  - Genetic Markers
KW  - Humans
KW  - Hydroxyproline
KW  - analysis
KW  - Idiopathic Pulmonary Fibrosis
KW  - chemically induced
KW  - In Vitro Techniques
KW  - Macrophages, Alveolar
KW  - Mice
KW  - Mice, Transgenic
KW  - Signal Transduction
KW  - Syndecan-2
KW  - physiology
KW  - Tissue Array Analysis
KW  - Transforming Growth Factor beta1
KW  - Up-Regulation
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1164/rccm.201303-0434OC
ER  -